Share on facebook
Share on twitter
Share on linkedin

ChatGPT and generative AI land in pharma marketing with sense of awe — and plenty of caution

Illustration: Assistant Editor Kathy Wong for Endpoints News

AI has arrived and the Pharma industry needs to step enthusiastically into the future while building guiderails and protocols to keep the output both factual and safe. Generative AI is bringing great leaps forward in generating content at speed and volume and both agencies and pharma companies can benefit provided that they understand the risks. Our Innovation Director Simon Wilson explains some of the issues and shares his experience (and his most recent avatar) in this discussion with Endpoints News (subscription required).


“Every day we are working towards changing the standard of care for both patients and HCPs. Not everyone can say they help to change lives in their job, and I am proud to say we do!”

Accelerating clinical research and development through the combined power of trials, labs, and data science.

Demonstrating the value of life-science innovations with evidence and real-world expertise.